Author Correction: Human SARS-CoV-2 challenge uncovers local and systemic response dynamics

Affiliations

• ¹ Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK. r.lindeboom@nki.nl.
• ² The Netherlands Cancer Institute, Amsterdam, The Netherlands. r.lindeboom@nki.nl.
• ³ UCL Respiratory, Division of Medicine, University College London, London, UK.
• ⁴ Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.
• ⁵ Wellcome MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
• ⁶ Research Department of Infection, Division of Infection and Immunity, University College London, London, UK.
• ⁷ Department of Infectious Disease, Imperial College London, London, UK.
• ⁸ Department of Microbiology, Faculty of Science, and Integrative Computational BioScience Center, Mahidol University, Bangkok, Thailand.
• ⁹ Ensocell Therapeutics, BioData Innovation Centre, Wellcome Genome Campus, Hinxton, UK.
• ¹⁰ Department of Infectious Diseases, University College London Hospital, London, UK.
• ¹¹ hVIVO, London, UK.
• ¹² Division of Infection and Immunity, Institute of Immunity and Transplantation, University College London, London, UK.
• ¹³ UCL Great Ormond Street Institute of Child Health, London, UK.
• ¹⁴ UCL Respiratory, Division of Medicine, University College London, London, UK. m.nikolic@ucl.ac.uk.
• ¹⁵ Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK. sat1003@cam.ac.uk.
• ¹⁶ Theory of Condensed Matter, Cavendish Laboratory, Department of Physics, University of Cambridge, Cambridge, UK. sat1003@cam.ac.uk.
• ¹⁷ Wellcome MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK. sat1003@cam.ac.uk.